|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_on1081038825 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
190107s2018 enka ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d YDX
|d EBLCP
|d UKMGB
|d UKAHL
|d OCLCQ
|d ELBRO
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB912898
|2 bnb
|
016 |
7 |
|
|a 019205923
|2 Uk
|
020 |
|
|
|a 9781527523777
|q (electronic bk.)
|
020 |
|
|
|a 1527523772
|q (electronic bk.)
|
020 |
|
|
|z 1527506126
|
020 |
|
|
|z 9781527506121
|
029 |
1 |
|
|a UKMGB
|b 019205923
|
035 |
|
|
|a (OCoLC)1081038825
|
037 |
|
|
|a 9781527523777
|b Cambridge Scholars Publishing
|
050 |
|
4 |
|a RM301.25
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Smith, Robert E.,
|d 1951-
|e author.
|
245 |
1 |
0 |
|a Systems thinking in medicine and new drug discovery.
|n Volume two /
|c by Robert E. Smith.
|
264 |
|
1 |
|a Newcastle upon Tyne :
|b Cambridge Scholars Publishing,
|c 2018.
|
300 |
|
|
|a 1 online resource (xiv, 333 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed January 8, 2019).
|
505 |
0 |
|
|a Intro; Contents; Preface; Chapter One; 1.1 P4 medicine: predictive, preventive, personalized and participatory; 1.2 Systems primary care medicine; 1.3 Causality in P4SM; 1.4 Explanation, prediction and control in P4 me; 1.5 What P4 medicine does; 1.6 Examples of P4 medicine; 1.7 Important collaborations in P4 medicine; 1.8 P4 and evidence based medicine; 1.9 The Advancing Regulatory Science Initiative; 1.10 The voices of the people; 1.11 Limitations of P4 medicine; 1.12 Metabolomics; 1.12.1 Introduction; 1.12.2 Comparison of LC-MS and GC-MS; 1.12.3 NMR in metabolomics
|
505 |
8 |
|
|a 1.12.4 Receiver operator characteristic (ROC) curves1.12.5 Acute kidney injury (AKI) metabolomics; 1.12.6 Chronic kidney disease (CKD) me; 1.12.7 Metabolomics of acute kidney injury; 1.12.8 Metabolomics of neonatal, pediatric and childhood kidney diseases; 1.12.9 Metabolomics of kidney cancer; 1.12.10 Proteomics; 1.13 Targeted radiation therapy; 1.14 Precision systems medicine that targets cancer stem cel; 1.15 Cancer prevention; 1.16 Systems medicine; References; Chapter Two; 2.1 Previous misconceptions caused by reductionist thinking; 2.2 Chemistry of free radicals and RONS
|
505 |
8 |
|
|a 2.3 How antioxidants really work2.3.1 Poorly liganded iron and the Fenton reaction; 2.3.2 The Nrf2/ARE system; 2.4 The role of the Keap1-Nrf2-ARE signaling system in preventing cardiovascular diseases; 2.5 Role of the Nrf2/ARE antioxidant system in cancer and neurodegenerative diseases; 2.6 Smoldering inflammation; 2.7 The complement system and toll-like receptors in health and disease; References; Chapter Three; 3.1 Nutrition; 3.1.1 Fats; 3.1.2 Protein; 3.1.3 Carbohydrates; 3.1.4 Vitamins and; 3.1.5 Mother's milk -- the only true superfood; 3.2 Role of Lifestyle; References; Chapter Four
|
505 |
8 |
|
|a 4.1 Introduction4.2 Epigenetic gene regulation; 4.3 Global climate change; References; Appendix; A1 Introduction; A2 The Nervous System; A2.1 Introduction; A2.2 Cells in the nervous system; A2.3 Regions of the brain; A2.4 Neurotransmitters, neurohormones and neuromodulators; A2.5 Small molecule neuroactive NO and CO; A3 The Endocrine System; A4 The Immune System; References; Abbreviations and Acronyms Used; Index
|
520 |
|
|
|a This second book in a two-volume set tells how the healthcare community is working with patients and their caregivers to help improve health using P4 medicine, proper nutrition and a healthy lifestyle. The healthcare community is finding ways to predict one's susceptibility to diseases, so they can be prevented from occurring, when possible. When diseases do emerge, it is developing personalized therapies and ways for patients to participate in their own healthcare. At the same time, systems thinking dispels many misconceptions, such as 'natural' foods and 'superfoods'. In fact, the only true.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
0 |
|a Integrative medicine.
|
650 |
|
0 |
|a Human biology.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
6 |
|a Chimie pharmaceutique.
|
650 |
|
6 |
|a Médecine intégrative.
|
650 |
|
6 |
|a Biologie humaine.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Drug development
|2 fast
|
650 |
|
7 |
|a Human biology
|2 fast
|
650 |
|
7 |
|a Integrative medicine
|2 fast
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1993859
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH35847252
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5628828
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1993859
|
938 |
|
|
|a eLibro
|b ELBO
|n ELB119486
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 15956206
|
994 |
|
|
|a 92
|b IZTAP
|